SENOREI LIMITED
Significant control: Shinichi Onuma (50–75%), Takashi Takenoshita (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Senorei Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Senorei Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
SENOREI LIMITED is an active private limited company (company number 14504354) incorporated on 24 November 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £22k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 58% on the prior period (£54k).
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Shinichi Onuma
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mr Takashi Takenoshita
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 November 20223 yrs ago
- Next accounts due
- 28 February 2027in 126 days
- Confirmation statement due
- 8 December 2026in 44 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £22k | — | — | — | — | — | 1 |
| 30 November 2023 | £54k | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £22,481 at 31 May 2025
- Net assets down 25% or more on the prior period-58.5% vs prior period
- Incorporated two to five years agoIncorporated 24 November 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 126 days
- Confirmation statement duein 44 days
- Accounts period endNet assets £22k · micro accounts
- Accounts period endNet assets £54k · micro accounts
- Incorporated
Similar companies in London
- SCIENZ LTDLondon · inc. Nov 2022
- VECTORBUILDER LIMITEDLondon · inc. Nov 2022
- TREAT THERAPEUTICS LTDLondon · inc. Nov 2022
- MICO BIO PHARMA LTDLondon · inc. Dec 2022
- CODIFY THERAPEUTICS LIMITEDLondon · inc. Nov 2022
- IXCHEL MEDICAL LTDLondon · inc. Dec 2022
All companies incorporated on 24 November 2022 · in Nov 2022.
Reminders for SENOREI LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.